In our Life Sciences division, the Company has an ongoing sales program with recent sales to one of the world’s largest manufacturers of vaccines. The Company is engaging with that customer to use AnteoBindTM in the development of their future new vaccines. If the current development work proceeds, the Company is targeting sales of AnteoBindTM to this customer, across the life of the vaccine.
Ann: Prospectus - Share Purchase Plan Offer and Options Offer, page-2
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.8¢ |
Change
0.001(2.86%) |
Mkt cap ! $48.69M | |||
| Open | High | Low | Value | Volume |
| 1.7¢ | 1.9¢ | 1.7¢ | $68.49K | 3.821M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 2045633 | 1.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.9¢ | 944151 | 8 |
View Market Depth
| Last trade - 15.25pm 25/07/2025 (20 minute delay) ? |
| ADO (ASX) Chart |